NCT00213525已完成不适用
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Healthy Controls
University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2004年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Identification of environmental factor
研究概览
简要总结
Scleroderma is an autoimmune disease of unknown origin. Recently, the role of environmental factors, and particularly toxic drug exposure, in the genesis of scleroderma has been suggested.
This prompted us to conduct this prospective, case-control, multicentric study, including 2 groups of subjects:
- 100 patients with scleroderma
- 300 sex- and age-matched healthy controls. The aim of our study is to determine whether exposure to toxics is higher in patients with scleroderma compared with healthy controls.
详细描述
The data of patients with scleroderma and healthy controls will be compared regarding:
- a standardized questionnaire about "cursus laboris" at initial inclusion
- a search for toxics in blood, urine and hair: at initial exvaluation, 6 month and 2 year-follow-up
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 76 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •patients with scleroderma with:
- •age range : 18 to 76 years
- •written consent
排除标准
- •patients with other connective-tissue disorders
- •pregnant women
- •patients with psychiatric conditions
- •unwritten consent
结局指标
主要结局
Identification of environmental factor
时间窗: Day 1
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Scleroderma RegistrySclerodermaSystemic SclerosisNCT00074568National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)5,000
Unknown
2 期
SCLERoderma et Adipose-DErived Stroma CellsSystemic SclerosisNCT02866552Assistance Publique Hopitaux De Marseille44
已完成
2 期
Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic SclerosisScleroderma, DiffuseDiffuse Cutaneous Systemic SclerosisNCT02503644Inventiva Pharma145
已完成
1 期
IL1-TRAP, Rilonacept, in Systemic SclerosisSclerodermaDiffuse SclerodermaDiffuse Systemic SclerosisSystemic SclerosisNCT01538719Boston University24
终止
1 期
Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic SclerosisSclerodermaNCT00282425Richard Burt, MD8
